Not yet recruiting
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
NCT05814848
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
Not specified